Delivery Order SPE2DB20D3101-SPE2DB25FRWB6
Award Date 9/22/25
Potential Completion Date 9/23/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $22,277.22 by the Defense Logistics Agency for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging of 10s. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 31, 2025. The award was executed on July 30, 2025, and represents a child contract under AmerisourceBergen's larger relationship with DLA as a...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 30, 2025, by the Defense Logistics Agency (DLA) for UBRELVY 100 MG tablets in unit dose packaging of 10 units, with a ceiling value of $1,009.99. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive procurement utilizing an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,338.57 to AmerisourceBergen Drug Corp for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging, quantities of 16. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and was competitively awarded without set-aside designation. The pharmaceutical will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging of 10 units, with a ceiling value of $18,754.48. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $13,759.20 to AmerisourceBergen Drug Corp for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit-dose packaging on September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $5,810.33 firm fixed-price delivery order from the Defense Logistics Agency for UBRELVY 50 mg tablets (10-count unit dose packaging). The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $6,244.42 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablet unit dose packages (16 count) on September 8, 2025, with completion expected by September 9, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's pharmaceutical supply support to federal military and healthcare systems. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,856.58 to AmerisourceBergen Drug Corp for UBRELVY 50 MG tablets (10 unit doses) on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract under the company's broader pharmaceutical supply agreement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging, 16-count configuration. This competitively awarded, non-set-aside delivery order carries a ceiling value of $9,658.97 with firm fixed pricing and an ultimate completion date of August 18, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $13,431.90 delivery order to AmerisourceBergen Drug Corp for UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging of 10 tablets on April 24, 2025, with completion targeted for April 25, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....